Published

River Capital exits Alderley Analytical to European firm

Summary by BusinessCloud.co.uk
Bioanalytical services specialist Alderley Analytical has been acquired by Dutch firm Synexa Life Sciences. Synexa is backed by major European healthcare investor Gilde Healthcare. Alderley Analytical, founded in 2013 and operational since 2014, has grown significantly since securing initial investment from River Capital and has established itself as a key player in supporting drug development programmes through discovery, pre-clinical safety te…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.